검색
Regeneron Pharmaceuticals Inc
REGN관심 목록에 추가
663.040USD
+11.130+1.71%
시장 운영 시간 （ET）시세는 15분 지연됩니다
69.62B시가총액
15.61P/E TTM
자세한 내용은 Regeneron Pharmaceuticals Inc 회사
Regeneron Pharmaceuticals, Inc. is a fully integrated biotechnology company. The Company invents, develops, manufactures, and commercializes medicines for people with serious diseases. Its products and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases. The Company is accelerating drug development using its proprietary technologies, such as VelociSuite, which produces optimized fully human antibodies and new classes of bispecific antibodies. VelociSuite consists of VelocImmune, VelociGene, VelociMouse, VelociMab, Veloci-Bi, VelociT, VelociHum, and other related technologies. Its marketed products include EYLEA (aflibercept); Dupixent (dupilumab); Libtayo (cemiplimab); Ordspono (odronextamab); Kevzara (sarilumab); Itepekimab; Linvoseltamab, and others.
Regeneron Pharmaceuticals Inc 정보
종목 코드 REGN
회사 이름Regeneron Pharmaceuticals Inc
상장일Apr 02, 1991
CEOSchleifer (Leonard S)
직원 수15106
유형Ordinary Share
회계 연도 종료Apr 02
주소777 Old Saw Mill River Road
도시TARRYTOWN
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호10591
전화17813705000
웹사이트https://www.regeneron.com/
종목 코드 REGN
상장일Apr 02, 1991
CEOSchleifer (Leonard S)
Regeneron Pharmaceuticals Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. George D. Yancopoulos, M.D., Ph.D
Dr. George D. Yancopoulos, M.D., Ph.D
Co-Chairman of the Board, President, Chief Scientific Officer
Co-Chairman of the Board, President, Chief Scientific Officer
1.13M
+0.00%
Dr. Leonard S. Schleifer, M.D., Ph.D
Dr. Leonard S. Schleifer, M.D., Ph.D
Co-Chairman of the Board, President, Chief Executive Officer, Founder
Co-Chairman of the Board, President, Chief Executive Officer, Founder
688.09K
+0.00%
Dr. Andrew J. Murphy, Ph.D.
Dr. Andrew J. Murphy, Ph.D.
Executive Vice President - Research
Executive Vice President - Research
52.21K
+0.06%
Mr. Joseph J. LaRosa
Mr. Joseph J. LaRosa
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
42.31K
-5.98%
Mr. Daniel P. Van Plew
Mr. Daniel P. Van Plew
Executive Vice President, General Manager - Industrial Operations and Product Supply
Executive Vice President, General Manager - Industrial Operations and Product Supply
35.18K
+0.02%
Mr. George L. Sing
Mr. George L. Sing
Independent Director
Independent Director
33.07K
+0.02%
Mr. Christopher R. Fenimore
Mr. Christopher R. Fenimore
Chief Financial Officer, Executive Vice President - Finance
Chief Financial Officer, Executive Vice President - Finance
21.80K
+0.07%
Mr. Arthur F. (Art) Ryan
Mr. Arthur F. (Art) Ryan
Independent Director
Independent Director
17.22K
-1.16%
Ms. Marion E. McCourt
Ms. Marion E. McCourt
Executive Vice President - Commercial
Executive Vice President - Commercial
14.49K
+0.82%
Dr. Michael S. Brown, M.D.
Dr. Michael S. Brown, M.D.
Independent Director
Independent Director
12.78K
+0.04%
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. George D. Yancopoulos, M.D., Ph.D
Dr. George D. Yancopoulos, M.D., Ph.D
Co-Chairman of the Board, President, Chief Scientific Officer
Co-Chairman of the Board, President, Chief Scientific Officer
1.13M
+0.00%
Dr. Leonard S. Schleifer, M.D., Ph.D
Dr. Leonard S. Schleifer, M.D., Ph.D
Co-Chairman of the Board, President, Chief Executive Officer, Founder
Co-Chairman of the Board, President, Chief Executive Officer, Founder
688.09K
+0.00%
Dr. Andrew J. Murphy, Ph.D.
Dr. Andrew J. Murphy, Ph.D.
Executive Vice President - Research
Executive Vice President - Research
52.21K
+0.06%
Mr. Joseph J. LaRosa
Mr. Joseph J. LaRosa
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
42.31K
-5.98%
Mr. Daniel P. Van Plew
Mr. Daniel P. Van Plew
Executive Vice President, General Manager - Industrial Operations and Product Supply
Executive Vice President, General Manager - Industrial Operations and Product Supply
35.18K
+0.02%
Mr. George L. Sing
Mr. George L. Sing
Independent Director
Independent Director
33.07K
+0.02%
자주 묻는 질문
Regeneron Pharmaceuticals Inc의 상위 5대 주주는 누구인가요?
Regeneron Pharmaceuticals Inc의 상위 5대 주주는 다음과 같습니다: Dr. George D. Yancopoulos, M.D., Ph.D
Regeneron Pharmaceuticals Inc(REGN)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, Regeneron Pharmaceuticals Inc의 주식을 보유한 기관은 총 2806곳이며, 이들이 보유한 주식의 총 가치는 약 94.67M로 전체 발행 주식의 91.89%를 차지합니다. 이는 2025Q4 대비 -1673066.00 증가한 수치입니다.
Regeneron Pharmaceuticals Inc의 최대 수익원은 무엇인가요?
2026Q1 기준, Regeneron Pharmaceuticals Inc의 Sanofi 부문이 가장 높은 매출을 기록했으며, 금액은 5.88B로 전체 매출의 41.02%를 차지했습니다.